Overview of 5-Amino-1MQ for Research
5-Amino-1MQ (5-amino-1-methylquinolinium) is a small-molecule organic compound that has attracted attention in biochemical research due to its ability to modulate the activity of nicotinamide N-methyltransferase (NNMT). NNMT catalyzes the transfer of a methyl group from S-adenosyl methionine to nicotinamide, producing 1-methylnicotinamide. This reaction is a key metabolic step that influences cellular levels of NAD+, S-adenosyl methionine, and other methyl donors, with downstream effects on gene expression, cellular senescence, and energy homeostasis. By selectively inhibiting NNMT, 5-Amino-1MQ enables researchers to dissect these pathways in controlled laboratory settings.
Structural studies indicate that 5-Amino-1MQ occupies the nicotinamide-binding site of NNMT, with its quinolinium core and amino substituent forming specific interactions that confer high affinity. The compound is typically supplied as a crystalline salt, soluble in aqueous buffers for in vitro assays. All experimental applications of 5-Amino-1MQ are limited to laboratory research – it is not intended for human or veterinary use, and no therapeutic, diagnostic, or clinical applications are implied. Researchers should handle the material in accordance with institutional safety guidelines for laboratory chemicals.
GMP Manufacturing Standards for Research Peptides
Good Manufacturing Practice (GMP) represents a system of quality assurance that ensures each batch of a research compound is produced consistently, with defined specifications for identity, purity, and composition. For a 5-Amino-1MQ GMP manufacturer, this means adherence to documented protocols covering every stage of synthesis, purification, and packaging. Although originally developed for pharmaceutical ingredients, GMP principles are now widely applied to research-grade molecules where reproducibility is critical for credible experimental data.
Key elements of GMP production include validation of all equipment and processes, rigorous raw material qualification, and maintenance of a cleanroom environment with controlled temperature, humidity, and particulate levels. Personnel follow standard operating procedures and complete training records. A comprehensive batch record is compiled, tracing all steps from initial weighing of intermediates to final labeling. This documentation supports traceability and enables full investigation in the event of an out-of-specification result.
Quality Control Protocols in GMP Facilities
Within a GMP setting, quality control (QC) is not a single end-test but an integrated series of checks. During the synthesis of 5-Amino-1MQ, in-process controls monitor reaction progress by thin-layer chromatography or HPLC, ensuring that each intermediate meets acceptance criteria before proceeding. Purification steps, typically recrystallization or chromatographic separation, are validated to remove process-related impurities.
The final product undergoes a battery of analyses. Identification is confirmed by high-performance liquid chromatography (HPLC) retention time matching a reference standard, and mass spectrometry verifies the molecular ion corresponding to [M]+ of 5-Amino-1MQ (m/z approximately 174.1 for the cation). Purity is determined by HPLC peak area normalization, with typical specifications set at ≥98% area. Additional tests include appearance, solubility, water content (by Karl Fischer titration), and residual solvent analysis by gas chromatography. Stability studies are conducted under long-term (e.g., -20 °C, desiccated) and accelerated conditions to establish a recommended retest date, providing researchers with confidence that the compound will maintain its integrity throughout their experimental timeline.
Selecting a Reliable 5-Amino-1MQ Manufacturer
When evaluating a potential GMP manufacturer for 5-Amino-1MQ, procurement officers and principal investigators should conduct a thorough due diligence process. The first step is verification of the manufacturer’s GMP credentials. Ask for a copy of the GMP certificate and, if possible, the date of the last regulatory audit. A credible manufacturer will also hold certifications for related quality management systems, such as ISO 9001. Although no universal GMP standard exists specifically for non-pharmaceutical research chemicals, adherence to guidelines modeled after ICH Q7 (active pharmaceutical ingredients) or regional drug GMP codes indicates a serious commitment to quality. Additionally, consider the following points when assessing a supplier:
- Audit history: Request a recent GMP audit report or certificate, and confirm it was issued by a competent authority.
- Synthesis experience: Evaluate expertise in quaternary ammonium salts and heterocyclic chemistry, as these pose unique challenges.
- CoA detail: Ensure each batch is accompanied by a certificate showing actual numerical results for purity, identity, and residual solvents.
Beyond certifications, review the manufacturer’s track record in synthesizing nitrogen-containing heterocycles and hygroscopic compounds. Request a representative certificate of analysis (CoA) for a recent batch. The CoA should detail the test methods, acceptance limits, and actual numerical results – not merely a “pass” statement. Confirm that the impurity profile is disclosed, including any known process impurities or degradation products. A manufacturer reluctant to share such data may be cutting corners in their QC.
Transparency and Documentation
Full transparency is a hallmark of a trustworthy GMP supplier. The manufacturer should provide a detailed description of the synthetic route, including reagents, solvents, and catalysts used, so that academic researchers can assess the likelihood of carryover impurities. An impurity profile summary, with identification and quantification of by-products at or above 0.1%, enables proper risk assessment for sensitive biological assays.
Essential documents include a safety data sheet (SDS) that classifies the compound according to the Globally Harmonized System (GHS), describing hazards, safe handling, and disposal. Regulatory compliance documentation should be available, such as a statement that the product is for research use only and is not manufactured under any pharmacopeia monograph. The label on each vial must clearly bear the statement “For laboratory research use only. Not for human or veterinary use.” This labeling not only protects the manufacturer from misuse but also assists customs clearance and institutional biosafety committees.
Analytical Methods for 5-Amino-1MQ Quality Assurance
Rigorous analytical characterization underpins the reliability of any research compound. For 5-Amino-1MQ, the gold standard for purity assessment is reversed-phase HPLC with a UV detector set to an appropriate wavelength, typically 254 nm or the absorbance maximum of the quinolinium chromophore around 270–320 nm. The method must be able to separate 5-Amino-1MQ from structurally related analogues, such as the parent 1-methylquinolinium or amino-positional isomers. System suitability tests, including resolution between critical peak pairs and tailing factor, are performed before each analytical run.
Mass spectrometry (MS) provides unambiguous identity confirmation. Electrospray ionization in positive ion mode yields the molecular ion [M]+. Tandem MS can be used to generate a characteristic fragmentation pattern that serves as a further identity fingerprint. In addition, the mass spectrum can reveal the presence of chlorine or other counterions if the compound is supplied as a chloride salt. Quantitative assessment of residual solvents is performed by headspace gas chromatography according to ICH Q3C guidelines, ensuring that levels of solvents like dimethylformamide or acetone are below the permitted daily exposure limits. Elemental impurity testing by inductively coupled plasma mass spectrometry screens for heavy metals (lead, cadmium, arsenic, mercury) following ICH Q3D, although these are rarely a concern for well-synthesized small molecules. Comprehensive analytical data should be compiled on the CoA for each batch.
Global Supply Chain and Logistics
Procuring 5-Amino-1MQ from a GMP manufacturer often involves cross-border shipping, which introduces logistical complexities. The compound, though chemically stable as a dry solid, may be hygroscopic and is typically shipped in sealed glass vials under argon or nitrogen. Temperature-controlled packaging is used to prevent exposure to extreme heat during transit, especially in summer months. The manufacturer should validate that a temperature excursion during typical shipping durations (e.g., 5–7 days) does not compromise product quality, and include a temperature monitoring device if requested.
Customs documentation must accurately describe the shipment. 5-Amino-1MQ is generally classified as a laboratory reagent, not a pharmaceutical ingredient, and should be declared under an appropriate Harmonized System code for aromatic heterocyclic compounds. Pro-forma invoices and packing lists should state “Research chemical – not for human or veterinary use” to minimize delays. Many countries require additional permits or notifications for imported chemicals; the manufacturer’s logistics team should assist in identifying these requirements in advance. Lead times for GMP-produced 5-Amino-1MQ can range from a few weeks for a readily available batch to several months for custom synthesis, so planning is essential. Minimum order quantities are often set to cover the costs of GMP batch production, typically in the range of grams to tens of grams, depending on the synthetic complexity.
Regulatory Considerations for International Shipping
Each destination country enforces its own chemical control regulations. In the United States, the Toxic Substances Control Act (TSCA) may apply if the compound is not listed on the TSCA Inventory and is intended for a non-exempt use; however, research quantities used solely for laboratory studies may qualify for an exemption. In the European Union, the REACH regulation imposes registration obligations for substances imported above one tonne per year, but research and development quantities below that threshold are typically exempt. Importers should verify the status with local authorities.
Proper labeling of the outer package is critical. In addition to the commercial invoice and a packing slip, include a safety data sheet and a letter of non-hazard classification if the compound is considered non-dangerous goods. Some couriers may still classify it as a chemical and require specific handling. Partnering with a logistics company experienced in temperature-sensitive research materials can help navigate carrier restrictions on dry ice or gel packs. For destinations with a high risk of customs congestion, a door-to-door incoterm (e.g., DDP – delivered duty paid) may simplify the process, as the manufacturer arranges all import formalities. Ultimately, a reliable 5-Amino-1MQ GMP manufacturer will provide proactive logistic support to ensure the product arrives intact and compliant.
À usage exclusivement scientifique : The information provided here is for educational and procurement guidance purposes. 5-Amino-1MQ is a laboratory reagent intended solely for in vitro biochemical research by qualified professionals. It is not manufactured for, nor may it be used in, any clinical, therapeutic, diagnostic, or veterinary application. All handling must adhere to relevant institutional safety and ethical guidelines.
Réservé à la recherche. Ne pas utiliser chez l'homme ni chez les animaux.
